Stage III/IV Melanoma
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Tavo and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Either Pembrolizumab or Nivolumab Treatment (NCT03132675) | OncoSec Medical Incorporated | 2017-10-03 |
| A Trial Evaluating the Safety & Efficacy of Intra-Tumoral Ipilimumab in Combination With Intra-venous Nivolumab in Patients With Metastatic Melanoma (NCT02857569) | Gustave Roussy, Cancer Campus, Grand Paris | 2016-12-05 |
Track Stage III/IV Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.